Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
23 results:

  • 1. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
    Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
    Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tertiary lymphoid structures in pulmonary metastases of microsatellite stable colorectal cancer.
    Karjula T; Niskakangas A; Mustonen O; Puro I; Elomaa H; Ahtiainen M; Kuopio T; Mecklin JP; Seppälä TT; Wirta EV; Sihvo E; Yannopoulos F; Helminen O; Väyrynen JP
    Virchows Arch; 2023 Jul; 483(1):21-32. PubMed ID: 37337034
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
    Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
    Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
    Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
    Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer.
    Zhan Z; Shi-Jin L; Yi-Ran Z; Zhi-Long L; Xiao-Xu Z; Hui D; Pan YL; Pan JH
    Ann Med; 2023 Dec; 55(1):114-126. PubMed ID: 36503344
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fibroblast Activation Protein and Tertiary Lymphoid Structure in colorectal cancer Recurrence.
    Hayase S; Miyoshi N; Fujino S; Yasui M; Ohue M; Minami S; Kato S; Nagae A; Sekido Y; Hata T; Hamabe A; Ogino T; Takahashi H; Uemura M; Yamamoto H; Doki Y; Eguchi H
    Anticancer Res; 2022 Dec; 42(12):5897-5907. PubMed ID: 36456145
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of four immune subtypes in locally advanced rectal cancer treated with neoadjuvant chemotherapy for predicting the efficacy of subsequent immune checkpoint blockade.
    He L; Jin M; Jian D; Yang B; Dai N; Feng Y; Xiao H; Wang D
    Front Immunol; 2022; 13():955187. PubMed ID: 36238279
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
    Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
    Front Immunol; 2022; 13():962056. PubMed ID: 36189233
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Relationship between Tertiary Lymphoid Structure and the prognosis and Clinicopathologic Characteristics in Solid Tumors.
    Zhao Z; Ding H; Lin ZB; Qiu SH; Zhang YR; Guo YG; Chu XD; Sam LI; Pan JH; Pan YL
    Int J Med Sci; 2021; 18(11):2327-2338. PubMed ID: 33967609
    [No Abstract]    [Full Text] [Related]  

  • 11. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
    Kießler M; Plesca I; Sommer U; Wehner R; Wilczkowski F; Müller L; Tunger A; Lai X; Rentsch A; Peuker K; Zeissig S; Seifert AM; Seifert L; Weitz J; Bachmann M; Bornhäuser M; Aust D; Baretton G; Schmitz M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis.
    Lin X; Lin K; Lin C; Wang J; Tang Y
    Int Immunopharmacol; 2020 Nov; 88():106946. PubMed ID: 33182023
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tertiary Lymphoid Structures in colorectal cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
    Ahmed A; Halama N
    Anticancer Res; 2020 Nov; 40(11):6367-6373. PubMed ID: 33109574
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. R-chop immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.
    Zhao F; Qin Y; Yang J; Liu P; He X; Zhou L; Zhou S; Gui L; Zhang H; Wang X; Jiang S; Zhong Q; Zhou Y; Shi Y
    Asia Pac J Clin Oncol; 2020 Dec; 16(6):385-391. PubMed ID: 32779387
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell cancer.
    Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging.
    Heijs B; Holst-Bernal S; de Graaff MA; Briaire-de Bruijn IH; Rodriguez-Girondo M; van de Sande MAJ; Wuhrer M; McDonnell LA; Bovée JVMG
    Lab Invest; 2020 Sep; 100(9):1252-1261. PubMed ID: 32341520
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer.
    Yamaguchi K; Ito M; Ohmura H; Hanamura F; Nakano M; Tsuchihashi K; Nagai S; Ariyama H; Kusaba H; Yamamoto H; Oda Y; Nakamura M; Akashi K; Baba E
    Oncoimmunology; 2020; 9(1):1724763. PubMed ID: 32117589
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. colorectal follicular lymphoma: A case report.
    Wang ML; Chang J; Huang H; Fu W; Niu YC; Lu ML; Shrestha S
    Medicine (Baltimore); 2019 Jan; 98(3):e13985. PubMed ID: 30653103
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.
    Gouveia HS; Lopes SO; Faria AL
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.